首页|益气温阳活血方对气虚血瘀型CHF的应用效果及安全性分析

益气温阳活血方对气虚血瘀型CHF的应用效果及安全性分析

扫码查看
目的 探讨益气温阳活血方对气虚血瘀型慢性心力衰竭(chronic heart failure,CHF)的应用效果及安全性。方法 应用随机数表法将我院近3年收治的100例气虚血瘀型CHF患者分为观察组与对照组,每组各50例。对照组采用利尿剂、诺欣妥、倍他乐克等常规治疗,观察组在上述常规治疗基础上增加益气温阳活血方。对比其临床疗效、治疗前后血清相关指标、心功能指标与运动耐量及不良反应发生率。结果 观察组治疗总有效率96。00%高于对照组的80。00%(P<0。05);治疗后观察组氨基末端脑钠肽前体(NT-proBNP)、血浆去甲肾上腺素(NE)、醛固酮(ALD)低于对照组(P<0。05);治疗后观察组左心室射血分数(LVEF)、6分钟步行试验(6MWT)高于对照组,左心室收缩末期容积(LVESV)、左心室舒张末期容积(LVEDV)低于对照组(P<0。05);观察组不良反应发生率8。00%与对照组的12。00%相比,无统计学差异(P>0。05)。结论 针对气虚血瘀型CHF患者在常规西药治疗基础上增加益气温阳活血方可进一步提升其临床疗效,改善神经内分泌因子及NT-proBNP表达水平,提升心功能与运动耐力,且安全性较高。
The application effect and safety analysis of Yiqi Wenyang Huoxue Formula on chronic heart failure of Qi deficiency and blood stasis type
Objective To explore the application effect and safety of Yiqi Wenyang Huoxue Formula in the treatment of chronic heart failure with Qi deficiency and blood stasis type.Methods Using the random number table method,100 patients with CHF of Qi deficiency and blood stasis type admitted to our hospital in the past 3 years were divided into an observation group and a control group,with 50 cases in each group.The control group received conventional treatments such as diuretics,neonicotinoid,and betaloc,while the observation group received additional Yiqi Wenyang Huoxue Formula on the basis of the aforementioned conventional treatments.Compare its clinical efficacy,serum related indicators before and after treatment,cardiac function indicators and exercise tolerance,and finally compare its incidence of adverse reactions.Results The total effective rate of the observation group was 96.00%,higher than 80.00%of the control group(P<0.05).After treatment,levels of N-terminal pro brain natriuretic peptide(NT-proBNP),plasma noradrenaline(NE)and aldosterone(ALD)were lower in the observation group than in the control group(P<0.05).After treatment,the left ventricular ejection fraction(LVEF)and the 6-minute walk test(6MWT)in the observation group were higher than in the control group,while the left ventricular end systolic volume(LVESV)and left ventricular end diastolic volume(LVEDV)were lower than those in the control group(P<0.05).There was no statistically significant difference(P>0.05)in the incidence of adverse reactions between the observation group(8.00%)and the control group(12.00%).Conclusion For patients with chronic heart failure of Qi deficiency and blood stasis type,adding Yiqi Wenyang Huoxue Formula on the basis of conventional Western medicine treatment can further improve its clinical efficacy,improve the expression levels of neuroendocrine factors and NT-proBNP,enhance heart function and exercise endurance,and have high safety.

Yiqi Wenyang Huoxue FormulaQi deficiency and blood stasis typeChronic heart failureHeart function

王龙

展开 >

陕西省榆林市榆阳区妇幼保健院,陕西 榆林 719000

益气温阳活血方 气虚血瘀型 CHF 心功能

2025

首都食品与医药
《首都医药》杂志社

首都食品与医药

影响因子:0.389
ISSN:1005-8257
年,卷(期):2025.32(1)